Search research articles
Contact Us
Filters
Showing results (251-260 of 310) with videos related to
Page
of 31
Sort By:
Scientific Reports
|
April 24, 2022
Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine
Chiara Agrati, Concetta Castilletti, Delia Goletti, et al.
Chemmedchem
|
January 16, 2018
Development of Potent Inhibitors of the Mycobacterium tuberculosis Virulence Factor Zmp1 and Evaluation of Their Effect on Mycobacterial Survival inside Macrophages
Marco Paolino, Margherita Brindisi, Alessandra Vallone, et al.
IJID Regions
|
April 9, 2025
Inequities underlie the alarming resurgence of Tuberculosis as the world's top cause of death from an Infectious Disease - Breaking the silence and addressing the underlying root causes
Alimuddin Zumla, Suvanand Sahu, Lucica Ditiu, et al.
Plos One
|
October 17, 2008
Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study
Delia Goletti, Stefania Carrara, Carrara Stefania, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
April 8, 2023
End of the Bedaquiline patent - a crucial development for moving forward affordable drugs, diagnostics, and vaccines for infectious diseases in low- and middle-income countries
Eskild Petersen, David S Hui, Jean B Nachega, et al.
Biomedicines
|
March 29, 2023
The Third Dose of BNT162b2 COVID-19 Vaccine Does Not "Boost" Disease Flares and Adverse Events in Patients with Rheumatoid Arthritis
Andrea Picchianti Diamanti, Assunta Navarra, Gilda Cuzzi, et al.
Frontiers in Immunology
|
November 17, 2025
Minimal association between Th1-specific responses to COVID-19 vaccines and SARS-CoV-2 breakthrough infections in multiple sclerosis patients receiving disease-modifying therapies
Alessandra Aiello, Assunta Navarra, Shalom Haggiag, et al.
Journal of Translational Medicine
|
December 8, 2021
Multi-omics approach to COVID-19: a domain-based literature review
Chiara Montaldo, Francesco Messina, Isabella Abbate, et al.
International Journal of Molecular Sciences
|
May 27, 2023
Dynamic Evolution of Humoral and T-Cell Specific Immune Response to COVID-19 mRNA Vaccine in Patients with Multiple Sclerosis Followed until the Booster Dose
Serena Ruggieri, Alessandra Aiello, Carla Tortorella, et al.
The European Respiratory Journal
|
April 13, 2012
The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement
Dragos Bumbacea, Sandra M Arend, Fusun Eyuboglu, et al.
Page
of 31
Search research articles
Search
Showing results (251-260 of 310) with videos related to
Sort By:
Page
of 31
Scientific Reports
|
April 24, 2022
Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine
Chiara Agrati, Concetta Castilletti, Delia Goletti, et al.
Chemmedchem
|
January 16, 2018
Development of Potent Inhibitors of the Mycobacterium tuberculosis Virulence Factor Zmp1 and Evaluation of Their Effect on Mycobacterial Survival inside Macrophages
Marco Paolino, Margherita Brindisi, Alessandra Vallone, et al.
IJID Regions
|
April 9, 2025
Inequities underlie the alarming resurgence of Tuberculosis as the world's top cause of death from an Infectious Disease - Breaking the silence and addressing the underlying root causes
Alimuddin Zumla, Suvanand Sahu, Lucica Ditiu, et al.
Plos One
|
October 17, 2008
Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study
Delia Goletti, Stefania Carrara, Carrara Stefania, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
April 8, 2023
End of the Bedaquiline patent - a crucial development for moving forward affordable drugs, diagnostics, and vaccines for infectious diseases in low- and middle-income countries
Eskild Petersen, David S Hui, Jean B Nachega, et al.
Biomedicines
|
March 29, 2023
The Third Dose of BNT162b2 COVID-19 Vaccine Does Not "Boost" Disease Flares and Adverse Events in Patients with Rheumatoid Arthritis
Andrea Picchianti Diamanti, Assunta Navarra, Gilda Cuzzi, et al.
Frontiers in Immunology
|
November 17, 2025
Minimal association between Th1-specific responses to COVID-19 vaccines and SARS-CoV-2 breakthrough infections in multiple sclerosis patients receiving disease-modifying therapies
Alessandra Aiello, Assunta Navarra, Shalom Haggiag, et al.
Journal of Translational Medicine
|
December 8, 2021
Multi-omics approach to COVID-19: a domain-based literature review
Chiara Montaldo, Francesco Messina, Isabella Abbate, et al.
International Journal of Molecular Sciences
|
May 27, 2023
Dynamic Evolution of Humoral and T-Cell Specific Immune Response to COVID-19 mRNA Vaccine in Patients with Multiple Sclerosis Followed until the Booster Dose
Serena Ruggieri, Alessandra Aiello, Carla Tortorella, et al.
The European Respiratory Journal
|
April 13, 2012
The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement
Dragos Bumbacea, Sandra M Arend, Fusun Eyuboglu, et al.
Page
of 31